Board changes and a new Chair announced for 2023

OMIC will be without the incredible talents of several Board and Committee members whose terms expire at the close of 2022. 

Dr. Denise Chamblee distinguished herself as one of the most influential Board members in recent memory, serving on the Executive Committee and chairing the Risk Management and Nominating Committees. 

Dr. Bradley Fouraker similarly impacted OMIC as one of the most active voices on OMIC’s Board for more than fifteen years. His advocacy in both his home state of Florida and nationally has won him accolades among his peers at both OMIC and the American Academy of Ophthalmology. 

Dr. Pauline Merrill has contributed extensively and fiercely defended the interests of ophthalmology throughout her tenure at OMIC. Drs. Chamblee, Fouraker, and Merrill will be profoundly missed. 

Finally, we extend our heartfelt gratitude to Drs. Ho Sun Choi and Michelle Ying for their years of service on OMIC Committees. 

Dr. Robert Gold of Maitland, Florida will assume leadership of OMIC  in 2023

We are pleased to announce that Dr. Robert Gold of Maitland, Florida, has been elected Chair of the OMIC Board of Directors beginning 1/1/2023. Learn more about Dr. Gold here.


Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.